Biomarker Discovery: These companies invest in research and development to discover new biomarkers that can be used for disease diagnosis, prognosis, and treatment response prediction. By identifying and validating biomarkers, they contribute to the development of novel diagnostic and therapeutic approaches.
Clinical Trial Testing: Clinical diagnostics companies offer specialized testing services to support clinical trials. They help in patient stratification, ensuring that trial participants meet specific inclusion and exclusion criteria, and provide accurate and timely analysis of biomarkers and endpoints during the trial.
Collaboration and Data Sharing: Clinical diagnostics companies collaborate with academic institutions, research organizations, and pharmaceutical companies to share knowledge, expertise, and data. Such collaborations accelerate the pace of scientific discovery, foster innovation, and improve patient care through the translation of research findings into clinical applications.
In summary, clinical diagnostics companies contribute to the fight against infectious diseases through rapid and accurate diagnosis, surveillance, and test development for emerging pathogens. In precision oncology, they enable molecular profiling, companion diagnostics, and treatment monitoring. These companies also support clinical research by discovering biomarkers, offering clinical trial testing, and fostering collaboration and data sharing.